Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04280887
Other study ID # My Pad Protocol version 1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 3, 2018
Est. completion date June 30, 2022

Study information

Verified date November 2022
Source Lancashire Teaching Hospitals NHS Foundation Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Development a 'dry alarm' that can help children and adolescents become dry at night.


Description:

Enuresis / Bedwetting is a common problem causing much emotional distress. Most children are dry by the age of 5 years, but a significant number of older children still wet their bed. This can be very distressing for child and family. There is also an associated cost due to extra laundry and impact of lost sleep. Programmes to help children become dry at night often include the use of a moisture alarm. The alarms sound when the child begins to wet the bed, waking them up to go to the toilet instead. Most alarms work by detecting wetness, sounding the alarm when the child starts to pass urine. As such, they still need to change pyjamas and bed sheets. The investigators aim to develop a 'dry alarm' that can help children and adolescents become dry at night. The alarm will sound when the bladder is full, before the child passes urine. This would avoid wet beds. The investigators have engineered parts for this alarm, but need to work on making it ready for use. This device will enable children to have dry nights whilst learning bladder control. This study has several phases. The alarm will consist of a small box worn over the abdomen. The aim is to test this overnight, and adjust it for comfort and ease. The device uses a mini ultrasound machine, which measures how much urine is in the bladder. There will be a series of tests to calibrate the device compared to a clinical ultrasound device. Then children with enuresis/ bed wetting will wear it overnight. It will be linked to an alarm which will sound once the bladder is full. This particular study will determine the feasibility of the product, to confirm the design and specifications, including a comfort trial, calibration and comparison with clinical scans, and operating process prior to a future clinical trial. The total number of participants is 25 - however this will be split over the different phases of the trial. Comfort Trial - 5 Calibration trial 3 month testing phase - 10


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date June 30, 2022
Est. primary completion date June 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 7 Years to 12 Years
Eligibility Inclusion Criteria: - Age 7 years to 12 years - Bedwetting twice a week or more - Good understanding of English language - For the initial comfort trials and the calibration trial healthy volunteers may be invited to take part. Exclusion Criteria: - there is a medical cause for bedwetting - they have significant learning difficulties - they are obese (above 98th centile for Body Mass Index) - they have severe hearing impairment

Study Design


Intervention

Device:
MyPad
Ultrasound bed wetting alarm

Locations

Country Name City State
United Kingdom Lancashire Teaching Hospitals NHS Foundation Trust Preston

Sponsors (2)

Lead Sponsor Collaborator
Lancashire Teaching Hospitals NHS Foundation Trust University of Central Lancashire

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Bladder expansion Bladder size measurements, device is able to provide consistent readings 3 months
Primary Reduction in adverse events Number of adverse events measured over the three months - reduction over time 3 months
Secondary Comfort Comfort, design and tolerability of device using validated comfort tool 3 months
See also
  Status Clinical Trial Phase
Completed NCT02600676 - Transcutaneous Electric Nerve Stimulation (TENS) in Children With Enuresis N/A
Completed NCT02369445 - Investigation of Teacher-Mediated Toilet Training Using a Manualized Moisture Alarm Intervention N/A
Completed NCT01978210 - Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism N/A
Recruiting NCT06070675 - Comparison of a Paper and Automated Bladder Diary in Pediatric Patients N/A
Completed NCT01747343 - Toilet Training Toddlers and Preschoolers N/A
Recruiting NCT00437528 - Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity Phase 1
Recruiting NCT02699528 - The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder N/A
Withdrawn NCT01861145 - Intranasal Steroids for the Treatment of Nocturnal Enuresis With Associated Obstructive Sleep Apnea Phase 4
Completed NCT04260646 - Alarm Treatment for Combined Enuresis and Daytime Urinary Incontinence in Children N/A
Completed NCT00270621 - Family Help Program: Nighttime Enuresis Treatment Program Phase 2
Completed NCT01367080 - A Study to Compare the Pharmacokinetic Profiles of Etravil® Tablet 10mg and Etravil® Tablet 25mg Phase 1
Completed NCT00226122 - The Effect of Indomethacin in Monosymptomatic Enuresis Nocturnal Phase 4
Completed NCT05190601 - Uroflowmetry in Children With Enuresis Nocturnal
Withdrawn NCT03478813 - Voiding School as a Treatment of Children's Day-time Incontinence or Enuresis N/A
Recruiting NCT03399877 - A Study on Accuracy Improvement of Repeated Measure Uroflowmetry- Electromyography N/A
Completed NCT01036841 - Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation Phase 4
Active, not recruiting NCT06185361 - Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis. N/A
Completed NCT00240812 - A Study to Determine if Ibuprofen in Combination With Pseudoephedrine HCl is More Effective Than Each Drug Alone in the Treatment of Nighttime Bedwetting Phase 2